|
Abstract
Aim: Ventricular septal
defect (VSD) is the most prevalent congenital cardiac malformation, yet its
molecular and genetic determinants remain incompletely understood. This study
aimed to elucidate the genetic contributors and biological pathways
implicated in VSD pathogenesis.
Methodology:
Thirty
genes most strongly associated with VSD were retrieved from DisGeNET. Gene
Ontology (GO) enrichment was performed across biological process, cellular
component and molecular function categories. Pathway enrichment utilised
WikiPathways, whilst metabolite and drug interaction profiling employed HMDB
and DrugMatrix platforms. Tissue-specific and subcellular analyses were
conducted via Jensen database resources, with all computations performed in R
(v4.4.2).
Results:
GO
enrichment highlighted terms encompassing cardiac developmental biology,
morphogenetic architecture and transcriptional regulation. WikiPathways
analysis revealed significant enrichment for heart development (p = 1.58 × 10-15)
and cardiac progenitor differentiation (p = 1.46 × 10-8), with TBX1,
TBX5, GATA4 and NKX2-5 identified as central contributors. Tissue
profiling confirmed pronounced cardiac-specific enrichment, and
metabolite-drug screening identified associations with Simvastatin and
Losartan.
Interpretation:
These
findings delineate the genetic landscape and molecular circuitry underlying
VSD, underscoring critical roles of cardiac developmental genes and
regulatory networks. Such insights may inform future therapeutic strategies
and risk stratification for this common congenital anomaly.
Key
words: Congenital
heart disease, Cardiac development, Genetic pathways, Transcriptional
regulation, Ventricular septal defect
|